Interleukin-10 production and secretion in blood in relation to interleukin-10 A-1082G polymorphism in pregnant women with fetal growth restriction


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. To clarify risk factors for fetal growth restriction (FGR), to determine the features of a genotype by the interleukin (IL)-10 A-1082G polymorphism and its effect on the production and secretion of IL-10 by peripheral blood monocytes in women with FGR. Subjects and methods. A total of209pregnant women were surveyed. The investigators assessed IL-10A-1082G gene polymorphism by a real-time polymerase chain reaction assay, the intracellular production of IL-10 by monocytes by means of flow cytofluorometry, and IL-10 levels in the 24-hour monocyte culture supernatants by enzyme immunoassay. Results. The IL-10-1082AA genotype was more common in women with FGR. Changes were found in the synthesis and production of IL-10 by monocytes in relation to the allelic variant of the IL-10 A-1082G polymorphism. Conclusion. The most significant risk factors for FGD are tobacco smoking, extragenital pathology, and a compromised obstetric and gynecological history. The results of the study may suggest that the L-10 A-1082G polymorphism is an additional factor regulating the immune balance during pregnancy when FGR develops.

Texto integral

Acesso é fechado

Sobre autores

Anna Malyshkina

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation; Ivanovo State Medical Academy, Ministry of Health of the Russian Federation

Email: ivniimid@inbox.ru
doctor of medical sciences, professor, director

Yelena Boiko

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation

Email: Dr-Boyko@mail.ru
doctor of medical sciences, senior researcher, Department of Obstetrics and Gynecology

Natal’ya Sotnikova

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation; Ivanovo State Medical Academy, Ministry of Health of the Russian Federation

Email: niimid.immune@mail.ru
doctor of medical sciences, Professor, head. laboratory of clinical immunology

Irina Panova

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation

Email: ia_panova@mail.ru
doctor of medical sciences, assistant professor, head of Department of obstetrics and gynecology

Irina Fetisova

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation; Ivanovo State Medical Academy, Ministry of Health of the Russian Federation

Email: ivgenlab@gmail.com
doctor of medical sciences, Professor of the Department of Obstetrics and Gynecology, Medical Genetics

Dmitriy Voronin

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation

Email: niimid.immune@mail.ru
candidate of biological sciences, researcher of the clinical immunology laboratory

Polina Mileeva

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation

Email: pvasilevskai@gmail.com
obstetrician-gynecologist obstetric physiological department of the inpatient department of the clinic

Bibliografia

  1. Ажибеков С.А., Путилова Н.В., Третьякова Т.Б., Пестряева Л.А. Роль генетически детерминированных особенностей энергетического обмена в формировании плацентарной недостаточности с исходом в синдром задержки роста плода. Акушерство и гинекология. 2016; 11: 11-5.
  2. Макаров И.О., Юдина Е.В., Боровкова Е.И. Задержка роста плода. Врачебная тактика. М.: МЕДпресс-информ; 2016. 56с.
  3. Смирнова Н.Н., Куприенко Н.Б. Фетальное программирование патологии взрослых. Нефрология. 2012; 16(2): 111-7.
  4. Стрижаков А.Н., Игнатко И.В., Карданова М.А. Критическое состояние плода: определение, диагностические критерии, акушерская тактика, перинатальные исходы. Вопросы гинекологии, акушерства и перинатологии. 2015; 14(4): 5-14.
  5. Фетисова И.Н., Посисеева Л.В., Поляков А.В. Наследственные факторы при различных формах нарушения функции супружеской пары. Иваново: Издательство “Иваново”; 2009. 240с.
  6. Кудряшова А.В., Сотникова Н.Ю., Посисеева Л.В., Панова И.А., Веденеева М.В. Роль иммунной системы в формировании задержки внутриутробного развития плода. Иваново; 2009. 239с.
  7. Tsai P.Y., Li S.H., Chen W.N., Tsai H.L., Su M.T. Differential miR-346 and miR-582-3p еxpression in аssociation with selected maternal and fetal complications. Int. J. Mol. Sci. 2017; 18(7). pii: E1570. https://dx.doi. org/10.3390/ijms18071570.
  8. Ye K.J., Dai J., Liu L.Y., Peng M.J. Network-based gene function inference method to predict optimal gene functions associated with fetal growth restriction. Mol. Med. Rep. 2018 18(3): 3003-10. https://dx.doi.org/10.3892/ mmr.2018.9232.
  9. Трифонова Е.А., Габидулина Т. В., Агаркова Т.А., Сере брова В.Н., Бутко Ю.К., Ворожищева А.Ю., Юрьев С.Ю., Девятьярова Л.А., Минайчева Л.И., Степанов В.А. Анализ роли наследственной тромбофи-лии в развитии осложненного течения беременности. Фундаментальные исследования. 2012; 10-2: 337-44.
  10. Zhou H., Liu A., Zhou B., Zhao C., Jin G. Interleukin-10 gene rs1800896 polymorphism increases risk of acute pancreatitis. Medicine (Baltimore). 2017; 96(48): e9006. https://dx.doi.org/10.1097/MD.0000000000009006.
  11. Maruthi G., Vinish Ramachander V.R., Prasanna Latha komaravalli, Sureka T.K., Parveen Jahan. Association of Il-10 gene polymorphisms (Rs 1800896, Rs1800872) in breast cancer patients. Int. J. Med. Sci. Clin. Invent. 2017; 4(6): 3050-61. 10.18535/ijmsci/v4i6.19.
  12. Cochery Nouvellon E., Nguyen P., Attaoua R., Cornillet Lefebvre P., Mercier E., Vitry F. et al. Interleukin 10 gene promoter polymorphisms in women with pregnancy loss: preferential association with embryonic wastage. Inflamm. Res. 2015; 64(12): 963-69.
  13. Артемьева Ж.Г., Поздеева М.С. Влияние условий перинатального периода на развитие ребенка. Молодой ученый. 2017; 15: 546-8. Доступно по: https://moluch.ru/archive/149/42053/.
  14. Shea A.K., Steiner M. Cigarette smoking during pregnancy. Nicotine Tob. Res. 2008; 10(2): 267-78.
  15. Волошина И.М. Взаимосвязь характера течения беременности и наличия в анамнезе соматической и стоматологической патологии. Здравоохранение Российской Федерации. 2014; 58(1): 43-7.
  16. Радзинский В.Е., Смалько П.Я. Биохимия плацентарной недостаточности. М.: РУДН; 2001. 275с.
  17. Газиева И.А., Чистякова Г.Н., Ремизова И.И. Предикторная значимость показателей функционального состояния эндотелия и регуляция ангиогенеза в I. триместре беременности в развитии плацентарной недостаточности и ранних репродуктивных потерь. Вопросы гинекологии, акушерства и перинатологии. 2015; 14(2): 14-23.
  18. Azizieh F.Y., Raghupathy R. IL-10 and pregnancy complications. Clin. Exp. Obstet. Gynecol. 2017; 44(2): 252-58.
  19. Cornelius D.C., Cottrell J., Amaral L.M., LaMarca B. Inflammatory mediators: a causal link to hypertension during preeclampsia. Br. J. Pharmacol. 2018; 176(12): 1914-21. https://dx.doi.org/10.1111/bph.14466.
  20. Al-Azemi M., Raghupathy R., Azizieh F. Pro-inflammatory and antiinflammatory cytokine profiles in fetal growth restriction. Clin. Exp. Obstet. Gynecol. 2017; 44(1): 98-103.
  21. Kwak-Kim J., Bao S., Lee S.K., Kim J.W., Gilman-Sachs A. Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am. J. Reprod. Immunol. 2014; 72(2): 129-40. https://dx.doi.org/10.1111/aji.12234.
  22. Машкина Е.В., Коваленко К.А., Миктадова А.В., Волосовцова Г.И., Сараев К.Н. Анализ экспрессии гена Il-10 в децидуальной и хорионической тканях при невынашивании беременности. Научное обозрение. Биологические науки. 2014; 1: 86-7. Доступно по: https://science-biology. ru/ru/article/view?id=109.
  23. Gonzalez-Galarza F.F., McCabe A., Melo Dos Santos E.J., Takeshita L., Ghattaoraya G., Jones A.R., Middleton D. Allele frequency net database. Methods Mol. Biol. 2018; 1802: 49-62.
  24. O’Garra A., Barrat F.J., Castro A.G., Vicari A., Hawrylowicz C. Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 2008; 223(1): 114-31.
  25. Нефедова Д.Д., Линде В.А., Левкович М.А. Иммунологические аспекты беременности (обзор литературы). Медицинский вестник Юга России. 2013; 4: 16-21.
  26. Чистякова Г.Н., Газиева И.А., Ремизова И.И., Черданцева Г.А. Оценка продукции цитокинов при беременности, осложненной угрозой прерывания в первом триместре. Фундаментальные исследования. 2005; 5: 96-8.
  27. Lee Y.H., Kim J.H., Song G.G. Meta-analyses of associations between interleukin-10 polymorphisms and susceptibility to recurrent pregnancy loss. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016; 200: 51-7. https://dx.doi. org/10.1016/j.ejogrb.2016.02.032.
  28. Shi X., Xie X., Jia Y., Li S. Maternal genetic polymorphisms and unexplained recurrent miscarriage: a systematic review and meta-analysis. Clin. Genet. 2017; 91(2): 265-84. https://dx.doi.org/10.1111/cge.12910.
  29. Rijhsinghani A.G., Thompson K., Tygrette L., Bhatia S.K. Inhibition of interleukin-10 during pregnancy results in neonatal growth retardation. Am. J. Reprod. Immunol. 1997; 37(3): 232-5.
  30. Cheng S.B., Sharma S. Interleukin-10: a pleiotropic regulator in pregnancy. Am. J. Reprod. Immunol. 2014; 73(6): 487-500. https://dx.doi.org/10.1111/ aji.12329.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2019

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies